首页
订购/客服:400-666-5481

BAY-1797

    
10mM in DMSO

BAY-1797

源叶(MedMol)
V54193 一键复制产品信息
2055602-83-8
C20H17ClN2O4S
416.88
货号 规格 价格 上海 北京 珠海 重庆 武汉 购买数量
V54193-1ml
10mM in DMSO

¥670.00

货期:3-5天 - - - -
产品介绍 参考文献 质检证书(COA) 摩尔浓度计算器 相关产品
产品描述:

BAY-1797 是一种高效、具有口服活性的,选择性的 P2X4 拮抗剂,对人 P2X4 的 IC50 为 211 nM。BAY-1797 在其它 P2X 离子通道上没有或表现出很弱的活性。BAY-1797 具有抗伤害和抗炎作用。

靶点: IC50: 211 nM (human P2X4), >50 μM (human P2X1), >30 μM (human P2X23), 8.3 μM (human P2X3), 10.6 μM (human P2X7).;P2XReceptor
体外研究: BAY-1797 inhibits human, mouse, and rat P2X4 in 1321N1 cells with IC50s of 108 nM, 112 nM, and 233 nM, respectively.
BAY-1797 exerts no measurable activity on hERG and carbonic anhydrase II (both IC50>10 μM). BAY-1797 is also tested against a panel of off-targets, including G-protein coupled receptors (GPCRs), ion channels, kinases, and transporters at 10 μM. An inhibitory activity against the dopamine transporter (DAT, IC50 2.17 μM) was revealed as the only hit.
体内研究: BAY-1797 (12.5-50 mg/kg; p.o.) shows a significant induction of PGE2 levels in the inflamed paw in the mouse Complete Freund’s Adjuvant (CFA) inflammatory pain model.
BAY-1797 (50 mg/kg; once daily for multiple p.o. administrations) induces a significant reduction of the ipsilateral paw load 24 and 48 h after CFA injection.
参考文献: 1. Werner S, et al. Discovery and Characterization of the Potent and Selective P2X4 Inhibitor N-[4-(3-Chlorophenoxy)-3-sulfamoylphenyl]-2-phenylacetamide (BAY-1797) and Structure-Guided Amelioration of Its CYP3A4 Induction Profile. J Med Chem. 2019 Dec 26;62
溶解性: Soluble  in  DMSO
保存条件: -80℃(运输条件:冰袋低温运输)
配置溶液浓度参考:
1mg 5mg 10mg
1 mM 2.399 ml 11.994 ml 23.988 ml
5 mM 0.48 ml 2.399 ml 4.798 ml
10 mM 0.24 ml 1.199 ml 2.399 ml
50 mM 0.048 ml 0.24 ml 0.48 ml
注意: 部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。

参考文献

质检证书(COA)

如何获取质检证书(COA)?
请输入货号和一个与之匹配的批号。
例如:
批号:JS298415 货号:S20001-25g
在货品标签上如何找到货号和批号?

摩尔浓度计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)

=
×
×